Fig. 1. Positive and Negative Symptom Scale (PANSS) scores for the amisulpride and cognitive behavioral therapy (CBT) groups. (A) PANSS Positive scores; F=0.09, p=0.77. (B) PANSS Negative scores; F=0.51, p=0.49. (C) PANSS General Psychopathology scores; F=4.95, p=0.04.

Clinical Psychopharmacology and Neuroscience 2019;17:250~260 https://doi.org/10.9758/cpn.2019.17.2.250

© Clin Psychopharmacol Neurosci